lobbying_activities: 3184563
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 3184563 | b802b3d8-9f3a-4bb5-afb8-188872da3d83 | Q2 | KEEFE STRATEGIES LLC (FKA KEEFE SINGISER PARTNERS) | 401105192 | CVS HEALTH | 2024 | second_quarter | HCR | Issues involving lowering the cost of healthcare and prescription drug prices; quality healthcare, patient outcomes, and healthcare delivery. | HOUSE OF REPRESENTATIVES,SENATE | 30000 | 0 | 0 | 2024-06-28T09:00:35-04:00 |